OBJECTIVE: The aim of this study was to compare direct, indirect, and societal (direct plus indirect) costs between patients with and without migraine (controls). METHODS: Patients with migraine were identified from MarketScan claims and Health and Productivity Management databases from January 1, 2010, to December 31, 2013, and were propensity score matched (1:1) to controls. RESULTS: Patients with migraine (N = 26,647) were matched to controls, of whom 4323 were matched for work absence and 26,212 for short-term disability eligibility. Mean annualized direct costs ($13,032 vs $3234), indirect costs due to absence ($4104 vs $3531) and short-term disability ($1131 vs $52), and societal costs due to absence ($16,043 vs $6938) and short-term disability ($14,278 vs $3182) were all significantly higher (P < 0.001) for those patients with migraine versus controls, respectively. CONCLUSION: Migraine imposes high direct and indirect economic burden on payers and society due to significantly higher work productivity loss than controls.
OBJECTIVE: The aim of this study was to compare direct, indirect, and societal (direct plus indirect) costs between patients with and without migraine (controls). METHODS:Patients with migraine were identified from MarketScan claims and Health and Productivity Management databases from January 1, 2010, to December 31, 2013, and were propensity score matched (1:1) to controls. RESULTS:Patients with migraine (N = 26,647) were matched to controls, of whom 4323 were matched for work absence and 26,212 for short-term disability eligibility. Mean annualized direct costs ($13,032 vs $3234), indirect costs due to absence ($4104 vs $3531) and short-term disability ($1131 vs $52), and societal costs due to absence ($16,043 vs $6938) and short-term disability ($14,278 vs $3182) were all significantly higher (P < 0.001) for those patients with migraine versus controls, respectively. CONCLUSION:Migraine imposes high direct and indirect economic burden on payers and society due to significantly higher work productivity loss than controls.
Authors: Olivia A J Begasse de Dhaem; Jacqueline French; Chris Morrison; Kimford J Meador; Dale C Hesdorffer; Sabrina Cristofaro; Mia T Minen Journal: Epilepsy Behav Date: 2019-06-07 Impact factor: 2.937
Authors: Linda Harris; Gilbert L'Italien; Anil Kumar; Prafullakumar Seelam; Chris LaVallee; Vladimir Coric; Richard B Lipton Journal: Headache Date: 2022-03-28 Impact factor: 5.311
Authors: Jennifer L Nguyen; Kiraat Munshi; Samuel K Peasah; Elizabeth C S Swart; Monal Kohli; Rochelle Henderson; Chester B Good Journal: J Headache Pain Date: 2022-08-28 Impact factor: 8.588